Eterna Therapeutics Announces Expansion of Scientific Advisory Board
Dr. Jerome Zeldis and Dr. Blythe Sather bring exceptional backgrounds in cell therapy and solid tumorsCAMBRIDGE, Mass., Jan.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives Consensus Rating of “Hold” from Brokerages
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has earned a consensus rating of “Hold” from the fifteen research ...
Barclays Keeps Their Buy Rating on Legend Biotech (LEGN)
Barclays analyst Gena Wang maintained a Buy rating on Legend Biotech (LEGN – Research Report) today and set a price target of $94.00. The ...
Larimar Therapeutics' SWOT analysis: stock potential hinges on FA treatment
Larimar Therapeutics, Inc. (NASDAQ:LRMR), with a market capitalization of $228 million, is a clinical-stage biopharmaceutical ...
Analysts Set Expectations for PTCT FY2025 Earnings
Investment analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for PTC Therapeutics in a report released on Tuesday, January 21st. Cantor Fitzgerald analyst K. Kluska expects that the ...
Analysts Offer Insights on Healthcare Companies: PTC Therapeutics (PTCT), COMPASS Pathways (CMPS) and Cogstate Ltd (OtherCOGZF)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on PTC Therapeutics (PTCT – Research Report), ...